Details | Number |
---|---|
Number of patients | 146 |
Ludman 2011 [16] | 29 (20%) |
Crimi 2013 [17] | 65 (45%) |
Bulluck 2016 [18] | 12 (8%) |
Bulluck 2016 [19] | 40 (27%) |
Male | 129 (88%) |
Age (years) | 59 ± 12 |
Diabetes Mellitus | 15 (10%) |
Hypertension | 67 (46%) |
Smoking | 64 (44%%) |
Dyslipidemia | 47 (32%) |
Chest pain onset to PPCI time (minutes) | 184 [135–282] |
Infarct artery (%) | |
  LAD | 109 (75%) |
  RCA | 29 (20%) |
  Cx | 8 (6%) |
TIMI flow pre-PPCI | |
   0 | 129 (89%) |
   1 | 7 (5%) |
   2 | 4 (3%) |
   3 | 4 (3%) |
TIMI flow post-PPCI | |
   0 | 2 (1%) |
   1 | 2 (1%) |
   2 | 23 (16%) |
   3 | 117 (82%) |
Timing of acute CMR | 4 ± 2 days |
Timing of follow-up CMR | 4 (4–5) months |
CMR findings- acute | |
  LVEDV | 156 (132–183) ml |
  LVESV | 80 (64–103) ml |
  LVM | 121 (104–145) g |
  LVEF | 47 ± 9% |
  MI size | 24.6 ± 12.1%LV |
  MVO | 96 (66%) |
CMR findings- follow-up | |
  LVEDV | 165 (141–201) ml |
  LVESV | 82 (60–109) ml |
  LVM | 106 (90–132) g |
  LVEF | 50 ± 11% |
  MI size | 17.8 ± 10.1%LV |